Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high‐risk Chinese individuals-Reference-Cited by-同舟云学术

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high‐risk Chinese individuals

Published:2019-12-31 Issue:2 Volume:111 Page:647-657
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Shao Di¹²^ORCID,Cheng Shaomin¹²,Guo Fengming¹²,Zhu Changbin¹,Yuan Yuying¹,Hu Kunling¹²,Wang Zhe¹,Meng Xuan¹,Jin Xin¹,Xiong Yun¹,Chai Xianghua¹,Li Hong¹,Zhang Yu¹,Zhang Hongyun¹,Liu Jihong³,Ye Mingzhi¹²

Affiliation:

1. BGI Genomics BGI‐Shenzhen Shenzhen China

2. BGI‐Guangzhou Medical Laboratory BGI‐Shenzhen Guangzhou China

3. Department of Gynecology Sun Yat‐sen University Cancer Center Guangzhou China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14242

Reference39 articles.

1. Cancer statistics, 2013

2. Cancer statistics in China, 2015

3. Comprehensive molecular portraits of human breast tumours

4. Integrated genomic analyses of ovarian carcinoma

5. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of medical knowledge toward genetic testing for individuals with hereditary breast and ovarian cancer syndrome in Brazil;Preventive Medicine Reports;2023-10

2. Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel;PLOS ONE;2023-09-01

3. Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy;Cancer Immunology, Immunotherapy;2023-07-18

4. Prevalence of germline mutations in women with breast and/or ovarian cancer in a tertiary care center in Pune, India;International Journal of Molecular and Immuno Oncology;2023-06-03

5. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database;Cancer Medicine;2023-04-25